3140 related articles for article (PubMed ID: 7470278)
21. Complement deposition on immune complexes reduces the frequencies of metabolic, proteolytic, and superoxide oscillations of migrating neutrophils.
Amit A; Kindzelskii AL; Zanoni J; Jarvis JN; Petty HR
Cell Immunol; 1999 May; 194(1):47-53. PubMed ID: 10357880
[TBL] [Abstract][Full Text] [Related]
22. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
[TBL] [Abstract][Full Text] [Related]
23. [Circulating immune complexes in the serum in Hodgkin's disease].
Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N
Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679
[TBL] [Abstract][Full Text] [Related]
24. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
Cojocaru M; Serbănescu A; Cojocaru IM
Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin classes, complement factors and circulating immune complexes in chronic sinusitis patients.
Ogunleye AO; Arinola OG
Afr J Med Med Sci; 2001 Dec; 30(4):309-12. PubMed ID: 14510109
[TBL] [Abstract][Full Text] [Related]
26. [Immunologic disturbances in patients with idiopathic posterior uveitis].
Kubicka-Trzaska A
Klin Oczna; 2000; 102(4):253-8. PubMed ID: 11291295
[TBL] [Abstract][Full Text] [Related]
27. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
28. [Hormonal function of the thymus in malignant melanoma of the skin; the interrelation with immune system disorders].
Grinevich IuA; Labunets IF
Vopr Onkol; 1987; 33(6):46-52. PubMed ID: 3617600
[TBL] [Abstract][Full Text] [Related]
29. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
[TBL] [Abstract][Full Text] [Related]
30. [Circulating immune complexes in the serum of tumor patients].
Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R
Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331
[TBL] [Abstract][Full Text] [Related]
32. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
[TBL] [Abstract][Full Text] [Related]
33. [Immune complexes as markers in breast cancer and melanoma].
Cappellari A; Corradi G
Boll Ist Sieroter Milan; 1987; 66(4):303-7. PubMed ID: 3442620
[TBL] [Abstract][Full Text] [Related]
34. Biochemical studies of immune complexes. II. Purification of immune complexes from sera of patients with malignant melanoma.
Quay SC; Murphy GF; Mihm MC
Clin Immunol Immunopathol; 1983 Mar; 26(3):318-26. PubMed ID: 6872347
[TBL] [Abstract][Full Text] [Related]
35. Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors.
Litvak DA; Gupta RK; Yee R; Wanek LA; Ye W; Morton DL
J Am Coll Surg; 2004 Jan; 198(1):27-35. PubMed ID: 14698308
[TBL] [Abstract][Full Text] [Related]
36. Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.
Mouawad R; Spano JP; Comperat E; Capron F; Khayat D
Eur J Cancer; 2009 May; 45(8):1407-14. PubMed ID: 19157860
[TBL] [Abstract][Full Text] [Related]
37. Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system.
Manderson GA; Martin M; Onnerfjord P; Saxne T; Schmidtchen A; Mollnes TE; Heinegård D; Blom AM
Mol Immunol; 2009 Oct; 46(16):3388-98. PubMed ID: 19674792
[TBL] [Abstract][Full Text] [Related]
38. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
[TBL] [Abstract][Full Text] [Related]
39. [Changes of the complement system in myelodysplastic syndromes].
Villaescusa Blanco R; Arce AA; Santos RM; Fernández N
Sangre (Barc); 1998 Jun; 43(3):210-2. PubMed ID: 9741227
[TBL] [Abstract][Full Text] [Related]
40. Direct immunofluorescence on uninvolved, lesional and perilesional skin in patients with endemic pemphigus foliaceus (fogo selvagem).
Pegas JR; dos Reis VM
Med Sci Monit; 2004 Dec; 10(12):CR657-61. PubMed ID: 15567982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
